How do patients with chronic urticaria weigh efficacy, safety, and convenience when selecting therapy? This quiz, based on a JAMA Dermatology systematic review, explores patient values and preferences to...
At the American Association of Nurse Practitioners 2025 National Conference, Sharon Bryant, DNP, MSN, ACNP-BC, explored how to differentiate cervical spine injury from routine musculoskeletal complaints in...
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
How well do you understand the latest findings on fixed-duration acalabrutinib–venetoclax regimens in untreated chronic lymphocytic leukemia? Take this quiz to find out!
At ENDO 2025, researchers presented findings examining the relationship between social isolation and diabetes outcomes in adults older than 60 years of age. Presenting author Samiya Khan, MD, spoke with...
A recent study explored blood pressure reduction in midlife men and women. Which group showed the greatest improvement? Test your knowledge in our quiz!
New FDA-approved and investigational therapies target apoC-III to reduce triglycerides in familial chylomicronemia syndrome. Can you identify how these agents work?
A 2025 review in the Journal of Clinical Lipidology proposes a North American diagnostic score to help identify familial chylomicronemia syndrome. Can you recognize its key features?
Currently, 15 benzodiazepines are approved by the US Food and Drug Administration. Do you know which negative effect is associated with long-term use? Test your knowledge with our quiz!
If a patient presents with a GFR category G3a and a persistent albuminuria category of A2, to which risk category does he or she belong? Test your knowledge with our latest pop quiz!
